Cash & equivalents increased 30.9%
Cash & equivalents changed +30.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +30.9% from the comparable as-filed period.
Gross margin changed +730 basis points from the comparable as-filed period.
Gross profit changed +24.0% from the comparable as-filed period.
Net income changed +113.8% from the comparable as-filed period.
Operating income changed +21.5% from the comparable as-filed period.
Operating margin changed +2606 basis points from the comparable as-filed period.
Stock-based compensation changed -17.2% from the comparable as-filed period.
Revenue changed +7.5% from the comparable as-filed period.
Research & development changed -5.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.